Memorial Sloan-Kettering
Sophia sponsored a meeting gathering early adopters, pharma partners, and others to discuss the recently launched MSK-ACCESS, and soon-to-launch MSK-IMPACT kits.
Biden Cancer Moonshot Announces New Projects Focused on Decreasing Cancer Burden in Africa
Programs aim to improve screening tools and adherence, advance new point-of-care diagnostics, and increase access to precision medicine on the continent.
Sophia Genetics Sees Profitability in Next Two Years, Touts Liquid Biopsy Potential at JP Morgan
Sophia execs said the firm added 35 new core genomics customers in the fourth quarter of 2023 and 87 over the full year.
Sophia Genetics, Memorial Sloan Kettering, AstraZeneca Partner to Broaden Cancer Sequencing Access
The companies aim to create a decentralized global network for genomic cancer testing, including underserved regions where access remains limited.
Myriad Genetics, Memorial Sloan Kettering Partner to Study MRD Testing in Breast Cancer
The collaborators will evaluate the use of Myriad's MRD platform in predicting response to CDK4/6 inhibitors and in a chemotherapy neoadjuvant setting.
Apr 20, 2023
May 20, 2022
Sep 23, 2019
Apr 24, 2019